Advertisement
UK markets close in 1 hour 57 minutes
  • FTSE 100

    8,050.72
    +10.34 (+0.13%)
     
  • FTSE 250

    19,614.38
    -104.99 (-0.53%)
     
  • AIM

    753.48
    -1.21 (-0.16%)
     
  • GBP/EUR

    1.1664
    +0.0019 (+0.17%)
     
  • GBP/USD

    1.2462
    0.0000 (-0.00%)
     
  • Bitcoin GBP

    50,677.68
    -2,272.05 (-4.29%)
     
  • CMC Crypto 200

    1,343.98
    -38.60 (-2.79%)
     
  • S&P 500

    4,999.37
    -72.26 (-1.42%)
     
  • DOW

    37,963.49
    -497.43 (-1.29%)
     
  • CRUDE OIL

    82.73
    -0.08 (-0.10%)
     
  • GOLD FUTURES

    2,330.20
    -8.20 (-0.35%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,865.69
    -223.01 (-1.23%)
     
  • CAC 40

    7,974.18
    -117.68 (-1.45%)
     

Novartis’s 1Q18 Estimates: Expectations for Alcon

Novartis’s 1Q18 Estimates: Expectations for Alcon

Alcon, Novartis’s (NVS) eye care business, includes surgical products and vision care products. Alcon products are marketed in over 180 countries worldwide. Alcon is expected to report growth in revenue following increased demand for contact lenses and surgical products in 1Q18.